Peripheral Immune Profile and MRD Burden Following ASCT in Myeloma

Peripheral Immune Profile and MRD Burden Following ASCT in Myeloma

User Photo
ASHReport

4 years
594 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
David M. Foureau, PhD of Levine Cancer Institute gives an overview of his abstract, Peripheral Immune Profile and Minimal Residual Disease (MRD) Burden Following Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM), that was presented at the 58th ASH Annual Meeting in San Diego, CA.
Up Next Autoplay
>